☆ 4.6 Article

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

FRONTIERS IN MEDICINE (2021)

Related references

Note: Only part of the references are listed.

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Respiratory System

Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases

Jaime Signes-Costa et al.

Summary: The study found that patients with pre-existing lung diseases have a higher risk of mortality in the setting of COVID-19, especially those with COPD. Factors independently associated with all-cause mortality in patients with lung diseases include low oxygen saturation below 92% and elevated D-dimer levels.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

Add to Collection

Article Gastroenterology & Hepatology

Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer

Anu Aronen et al.

Summary: The study found that P-suPAR levels remained low in patients with chronic pancreatitis, but significantly higher in patients with pancreatic cancer. The levels of P-suPAR can be utilized to better differentiate between pancreatic cancer and chronic pancreatitis.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Rheumatology

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Hannah Bower et al.

Summary: The study estimated the absolute and relative risks for all-cause mortality and severe COVID-19 in patients with inflammatory joint diseases (IJDs) and antirheumatic therapies. Results showed that while the all-cause mortality in patients with IJDs was higher in 2020 compared to previous years, the relative risks were similar. The risks of hospitalization, admission to intensive care, and death due to COVID-19 were low among patients with IJDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Immunosuppression as a risk factor for COVID-19: a meta-analysis

Daniel Tassone et al.

Summary: This study found that immunosuppressed patients were not significantly at increased risk of COVID-19 infection compared to the general population.

INTERNAL MEDICINE JOURNAL (2021)

Add to Collection

Article Medical Laboratory Technology

Serum levels of the soluble urokinase plasminogen activator receptor (suPAR) correlates with disease activity in early rheumatoid arthritis and reflects joint damage over time

Helena Enocsson et al.

Summary: The study investigated the potential of suPAR in predicting or reflecting disease outcome in early rheumatoid arthritis (RA). Results showed that suPAR levels were associated with disease activity in early untreated RA and reflected joint damage at later stages. However, suPAR levels or changes over time did not have predictive value for disease outcome.

TRANSLATIONAL RESEARCH (2021)

Add to Collection

Article Engineering, Environmental

Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19

Fredy Saguti et al.

Summary: The study revealed that SARS-CoV-2 can be detected in wastewater, and its levels reflect the extent of transmission in society. Viral peaks occurred approximately every four weeks, preceding fluctuations in newly hospitalized patients by 19-21 days. Local differences in viral spread were observed, with varying amounts of virus found in wastewater from different areas of the same city, possibly reflecting the transmission patterns of infected individuals.

WATER RESEARCH (2021)

Add to Collection

Article Emergency Medicine

Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study

David T. Arnold et al.

Summary: Admission blood biomarkers have only moderate predictive value for predicting COVID-19 outcomes, while simple clinical features such as age and NEWS2 score outperform many biomarkers. IL-6 and suPAR had the best performance, and further studies should focus on the additive value of these biomarkers to routine care.

EMERGENCY MEDICINE JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Characteristics of hospitalised COVID-19 patients and parameters associated with severe pneumonia

Onur Turan et al.

Summary: This study analyzed the characteristics of hospitalized COVID-19 patients in Turkey and identified independent risk factors associated with severe pneumonia. It was found that advanced age, hypotension, anemia, and elevated levels of CRP and LDH were significant predictors of the severity of COVID-19 pneumonia. Age, blood pressure, complete blood count, and routine biochemical tests were highlighted as important parameters for evaluating the severity of COVID-19 pneumonia.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Infectious Diseases

Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study

Abderrahim Oulhaj et al.

Summary: The study demonstrated a significant association between plasma levels of suPAR and the incidence of severe complications in COVID-19 patients, with higher suPAR levels correlating with increased risk of adverse outcomes. For every 1 ng/mL increase in suPAR, there was a 58% rise in the hazard of developing the primary outcome. Therefore, suPAR shows promising prognostic utility in predicting severe complications in hospitalized COVID-19 patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR

Bugra Kerget et al.

Summary: Through measuring suPAR and KIM-1 levels, the study found that these biomarkers were significantly elevated in COVID-19 patients, with higher levels of KIM-1 in severe cases and lower levels of suPAR. KIM-1 may play an important role in the endocytosis of SARS-CoV-2 and could be a potential therapeutic target in the future, while suPAR may be involved in defense mechanisms and fibrinolysis, with low levels possibly being associated with poor prognosis in the early period.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

Gabriel Bsteh et al.

Summary: This study investigated the prevalence and outcomes of COVID-19 in multiple sclerosis patients, and found that overall, exposure to disease-modifying treatment and immunosuppressive therapy were not significantly associated with COVID-19 outcomes, providing reassuring evidence for individual risk assessment in MS patients.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States

Wataru Ando et al.

Summary: This study evaluated the impact of type 2 diabetes (T2D) and obesity on the hospitalization and critical care risks for COVID-19 patients. The results showed that T2D, obesity, and male sex were significantly associated with an increased risk of COVID-19 hospitalization, with complications from diabetes and obesity also increasing the risks of hospitalization and critical care for COVID-19 patients.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Immunology

SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic

Johanna Sjowall et al.

Summary: This study analyzed antibody data in samples from SLE patients collected before and during the SARS-CoV-2 pandemic, revealing that a large proportion of Swedish SLE patients showed signs of exposure to SARS-CoV-2 with minor impact on the course of SLE.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Predictors of Hypoxemia and Related Adverse Outcomes in Patients Hospitalized with COVID-19: A Double-Center Retrospective Study

Rabea Asleh et al.

Summary: Older age, higher BSA or BMI, lower lymphocyte counts, and elevated CRP were found to be independent predictors of low SpO2 in COVID-19 patients. Severe hypoxemia requiring ventilatory support, older age, and pre-existing comorbidities, such as underlying renal dysfunction and heart failure, were significantly associated with in-hospital mortality. These findings suggest that early assessment of hypoxemia predictors may aid in risk stratification and management of COVID-19 patients upon hospitalization.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone

Chrysi Keskinidou et al.

Summary: Endothelial dysfunction, coagulation, and inflammation biomarkers are increasingly recognized as prognostic markers for poor outcomes and mortality in severe and critical COVID-19. Our study found that in critically ill COVID-19 patients, certain biomarkers such as sVCAM-1, suPAR, and presepsin can still be reliable prognostic indicators for ICU mortality even after dexamethasone administration. Patients with higher levels of sVCAM-1 or suPAR had a greater risk of mortality.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, Research & Experimental

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Izzet Altintas et al.

Summary: The study investigated the association between plasma suPAR levels and the risk of 14-day mortality and mechanical ventilation in COVID-19 patients. It found that patients with suPAR <= 4 ng/mL had a lower risk of mortality, while those with suPAR > 6 ng/mL had a higher risk of mortality.

BIOMARKER INSIGHTS (2021)

Add to Collection

Article Immunology

Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1, 2020

NaTasha D. Hollis et al.

Summary: A study conducted in the United States from January 1 to October 1, 2020, revealed that Hispanic/Latino, non-Hispanic Black, American Indian/Alaskan Native, and Native Hawaiian/other Pacific Islander individuals had a significantly higher incidence of SARS-CoV-2 infection compared to non-Hispanic White individuals.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?

Chase T. Schultz-Swarthfigure et al.

Summary: Plasma suPAR levels were measured in cardiac surgical patients and found to predict prolonged ICU and hospital stay as well as prolonged ventilation postoperatively. Preoperative suPAR also showed predictive value, outperforming EuroSCORE II and CRP in predicting outcomes.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2021)

Add to Collection

Letter Economics

Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir's Value

Michaela R. Anderson et al.

PHARMACOECONOMICS-OPEN (2021)

Add to Collection

Review Critical Care Medicine

The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis

Qiangru Huang et al.

SHOCK (2020)

Add to Collection

Article Immunology

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Helena Enocsson et al.

JOURNAL OF AUTOIMMUNITY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis

Vageesh Jain et al.

INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2020)

Add to Collection

Article Virology

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19

Yong Gao et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

Burcin Oezdirik et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Clinical Characteristics of Covid-19 in New York City

Parag Goyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and sepsis admitted to the emergency department

Thomas Lafon et al.

ANNALS OF INTENSIVE CARE (2020)

Add to Collection

Editorial Material Infectious Diseases

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

Dimitrios Velissaris et al.

INFECTIOUS DISEASES AND THERAPY (2020)

Add to Collection

Article Medicine, General & Internal

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

Gita Vita Soraya et al.

MEDICINA CLINICA (2020)

Add to Collection

Article Genetics & Heredity

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

Athanasios Chalkias et al.

MOLECULAR DIAGNOSIS & THERAPY (2020)

Add to Collection

Review Medicine, General & Internal

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis

Jens Emil Vang Petersen et al.

BMJ OPEN (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial

Christoph D. Spinner et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Urology & Nephrology

Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI

Tariq U. Azam et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Evaluation of the clinical diagnostic value of traditional inflammatory markers and novel biomarkers in intracellular bacterial bloodstream infections

Mei-Fang Lin et al.

CYTOKINE (2020)

Add to Collection

Letter Critical Care Medicine

Plasma levels of the active form of suPAR are associated with COVID-19 severity

Mingxiang Huang et al.

CRITICAL CARE (2020)

Add to Collection

Letter Critical Care Medicine

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Nikoletta Rovina et al.

CRITICAL CARE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer

Sven H. Loosen et al.

JHEP REPORTS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy

Martin Schultz et al.

DISEASE MARKERS (2019)

Add to Collection

Article Gastroenterology & Hepatology

Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

Zuxiong Huang et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)

Add to Collection

Article Infectious Diseases

Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis

H. Schulman et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2019)

Add to Collection

Article Oncology

The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study

Hans C. Rolff et al.

JOURNAL OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Immunology

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Martin Hoenigl et al.

CLINICAL INFECTIOUS DISEASES (2019)

Add to Collection

Article Primary Health Care

Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department

Pratyush Kumar et al.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)

Add to Collection

Article Infectious Diseases

High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia

A. J. M. Loonen et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)

Add to Collection

Article Emergency Medicine

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study

Line Jee Hartmann Rasmussen et al.

EMERGENCY MEDICINE JOURNAL (2016)

Add to Collection

Article Multidisciplinary Sciences

Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis

Wentao Ni et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Review Medical Laboratory Technology

Soluble urokinase plasminogen activator receptor-A valuable biomarker in systemic lupus erythematosus?

Helena Enocsson et al.

CLINICA CHIMICA ACTA (2015)

Add to Collection

Article Multidisciplinary Sciences

Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection

Tuula K. Outinen et al.

PLOS ONE (2013)

Add to Collection

Article Medical Laboratory Technology

Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus

Helena Enocsson et al.

TRANSLATIONAL RESEARCH (2013)

Add to Collection

Article Gastroenterology & Hepatology

Soluble Urokinase Plasminogen Activator Receptor is Associated With Progressive Liver Fibrosis in Hepatitis C Infection

Marie-Luise Berres et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease

Kaija-Leena Kolho et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)

Add to Collection

Article Critical Care Medicine

Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study

Yara Backes et al.

CRITICAL CARE (2011)

Add to Collection

Review Cell Biology

Regulation of cell signalling by uPAR

Harvey W. Smith et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)

Add to Collection

Article Infectious Diseases

The prognostic value of the suPARnostic® ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms

Uffe V. Schneider et al.

BMC INFECTIOUS DISEASES (2007)

Add to Collection

Article Medicine, General & Internal

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2006)

Add to Collection

Article Immunology

Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome

SR Ostrowski et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.